James Shin

Stock Analyst at Deutsche Bank

(0)
# 4703
Out of 5,372 analysts
22
Total ratings
33.33%
Success rate
-15.91%
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
IMTX Immatics
Initiates Coverage On: Buy
10
6.16 62.34% 1 May 28, 2025
GILD Gilead Sciences
Upgrades: Buy
80 120
108.88 10.21% 2 Feb 18, 2025
MRK Merck & Co
Downgrades: Hold
128 105
79.36 32.31% 2 Feb 18, 2025
LLY Eli Lilly
Maintains: Buy
1025 1015
797.45 27.28% 4 Nov 4, 2024
AMGN Amgen
Reiterates: Hold
310 305
294.75 3.48% 2 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
55 60
69.88 -14.14% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
53 45
47.8 -5.86% 2 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
34.91 71.87% 1 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
150
188.32 -20.35% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
800
520.56 53.68% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.02 395.05% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.85 1311.76% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 70
n/a n/a 1 Dec 12, 2022